Adverse Event Rates Explained: Percentages vs. Relative Risk in FDA Trials
Aug 22 2026 - Health and Pharmaceuticals
Neoadjuvant therapy gives cancer treatment before surgery to shrink tumors and test drug response; adjuvant therapy follows surgery to kill leftover cells. New data shows neoadjuvant may be just as effective with fewer side effects, especially for lung and breast cancers.
read more© 2026. All rights reserved.